Sanofi-Aventis Picks Two U.S. Heads: Rothwell, Soriot On Management Cmte.
Executive Summary
Sanofi-Aventis' U.S. business will be overseen by Sanofi U.S. CEO Tim Rothwell and Aventis U.S. Pharmaceutical Operations Head Pascal Soriot under a draft structure of the company's management team
You may also be interested in...
Sanofi-Aventis Begins Operations; Markham, Senior Aventis Execs Depart
Sanofi-Aventis is beginning operations as a top 10 pharmaceutical company in the U.S
Sanofi-Aventis Begins Operations; Markham, Senior Aventis Execs Depart
Sanofi-Aventis is beginning operations as a top 10 pharmaceutical company in the U.S
Sanofi-Aventis Merger Clears FTC; Estorra Rights To Be Divested
Sanofi and Aventis will begin integrating management and operations following the Federal Trade Commission's July 28 approval of the merger of the two companies